LANXESS Targets Deeper Cost Cuts and Deleveraging Amid Weak Chemical Markets
Specialty chemicals company LANXESS is pursuing additional cost reductions and portfolio adjustments, expecting €170 million in further savings through 2028 from its FORWARD! program. The company reported Q2 EBITDA pre of €152 million, up from €94 million in Q1, and maintained its full-year 2026 EBITDA pre guidance at €450 million to €550 million. LANXESS aims to reduce net debt below 2.5 times EBITDA and restore investment-grade status, partly by monetizing its Envalior stake.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Regulatory Landscape of Virtual Currencies in Mainland China and Risks Associated with Using Overseas Trading Platforms
-
2
SKR Tokenomics Analysis: The Core Driver of the Solana Mobile Ecosystem
-
3
According to Bloomberg Markets: Large asset managers are deleveraging in the U.S. Treasury futures market, triggered by forced selling as cash yields approach multi-year highs.
-
4
Wall Street's Rate Shock Spreads Beneath AI-Fueled Market Rally, Driven by High Oil Prices and Borrowing Costs
-
5
iPhone Vulnerabilities Continue to Threaten Crypto Users, Older iOS Devices Remain at Risk
-
6
TypeSafe AI, the maker of the non-text AI model Jev, reached a valuation of $7.5 billion just weeks after its launch, with a16z leading an $870 million funding round.
-
7
Hungary Needs Significant Deficit Cut For Euro Path, Magyar Says
-
8
Base Network: Coinbase's Layer 2 Solution and Its Ecosystem Development Status
-
9
NEMO Token: Multi-Entity Identification and Trading Status
-
10
Neo (Antcoin) In-depth Analysis: The Technical Evolution and Ecosystem Layout of "China's Ethereum"
Markets Today
Recommended Reading







